Oklahoma reaches $250 million opioid settlement with drug distributors
Send a link to a friend
[June 28, 2022]
(Reuters) -Oklahoma has reached a
$250 million settlement with AmerisourceBergen Corp, Cardinal Health Inc
and McKesson Corp to resolve allegations the drug distributors
contributed to the opioid epidemic in the state, Oklahoma Attorney
General John O'Connor said on Monday.
O'Connor said Oklahoma recovered more money from the distributors than
the state would have received if it had joined a nationwide $26 billion
settlement that was announced last year.
The national settlement also includes Johnson & Johnson. Oklahoma sued
J&J separately, but in November the case was thrown out on appeal,
negating a $465 million trial judgment and undermining Oklahoma's legal
theories in its opioid litigation.
AmerisourceBergen said drug distributors have been forced to "walk a
legal and ethical tightrope" without clearer regulatory guidance on how
to protect consumers from legal but potentially dangerous drugs.
"A settlement will avoid years of protracted litigation, expedite the
movement of resources to communities impacted by opioid misuse and allow
our company to do what we do best – ensuring that health care facilities
like hospitals and community pharmacies have access to the medications
that patients and care providers need," AmerisourceBergen spokeswoman
Lauren Esposito said.
[to top of second column]
|
Tablets of the opioid-based Hydrocodone at a pharmacy in
Portsmouth, Ohio, June 21, 2017. REUTERS/Bryan Woolston
McKesson and Cardinal Health did not
immediately respond to requests for comment.
Oklahoma was the last state pursuing litigation
related to opioids against the three distributors. Alabama is still
suing Cardinal Health and AmerisourceBergen after settling with
McKesson. Local governments in West Virginia are pursuing cases
after the state settled.
Oklahoma will use at least 85% of the funds to help
abate the opioid addiction crisis in the state, according to
O'Connor.
The distributors have denied wrongdoing in the epidemic, which has
caused more than 500,000 U.S. overdose deaths during the past two
decades, according to government data.
(Reporting by Tom Hals in Wilmington, Delaware, and Dietrich Knauth
in New York; editing by Grant McCool and Leslie Adler)
[© 2022 Thomson Reuters. All rights
reserved.] This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |